A similar drug called tirzepatide (Zepbound) was approved by the FDA in December 2024 to treat sleep apnea in people with a BMI of 30 or higher
It helps: Increase insulin production to lower blood sugar Slow down digestion, so you feel full faster and longer Suppress appetite and reduce cravings When combined with a healthy diet and exercise, GLP-1 has been shown to promote significant, sustained weight loss and reduce the risk of heart disease, stroke, and other weight-related conditions
Bottom line: The cost of Rybelsus with UHC insurance is considerably lower than the retail price as long as your prescription plans drug formulary includes the drug
Activation of these sensors triggers PI3K/Akt signaling and eNOS activation, increasing NO production as well as promotion of nuclear factor erythroid 2-like 2 (Nrf2), responsible for antioxidant gene expression [206]
Currently, the FDA has not approved a generic version of Zepbound